APA

Neudorfer C., Shanab K., Jurik A., Schreiber V., Neudorfer C., Vraka C., Schirmer E., Holzer W., Ecker G., Mitterhauser M., Wadsak W. & Spreitzer H. (20150420). Development of potential selective and reversible pyrazoline based MAO-B inhibitors as MAO-B PET tracer precursors and reference substances for the early detection of Alzheimer's disease. : Bioorganic & medicinal chemistry letters.

Chicago

Neudorfer Catharina, Shanab Karem, Jurik Andreas, Schreiber Veronika, Neudorfer Carolina, Vraka Chrysoula, Schirmer Eva, Holzer Wolfgang, Ecker Gerhard, Mitterhauser Markus, Wadsak Wolfgang and Spreitzer Helmut. 20150420. Development of potential selective and reversible pyrazoline based MAO-B inhibitors as MAO-B PET tracer precursors and reference substances for the early detection of Alzheimer's disease. : Bioorganic & medicinal chemistry letters.

Harvard

Neudorfer C., Shanab K., Jurik A., Schreiber V., Neudorfer C., Vraka C., Schirmer E., Holzer W., Ecker G., Mitterhauser M., Wadsak W. and Spreitzer H. (20150420). Development of potential selective and reversible pyrazoline based MAO-B inhibitors as MAO-B PET tracer precursors and reference substances for the early detection of Alzheimer's disease. : Bioorganic & medicinal chemistry letters.

MLA

Neudorfer Catharina, Shanab Karem, Jurik Andreas, Schreiber Veronika, Neudorfer Carolina, Vraka Chrysoula, Schirmer Eva, Holzer Wolfgang, Ecker Gerhard, Mitterhauser Markus, Wadsak Wolfgang and Spreitzer Helmut. Development of potential selective and reversible pyrazoline based MAO-B inhibitors as MAO-B PET tracer precursors and reference substances for the early detection of Alzheimer's disease. : Bioorganic & medicinal chemistry letters. 20150420.